The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

All News

BioGaia’s probiotic reduces inflammation in patients with diverticulitis
Biotics and Supplements

BioGaia’s probiotic reduces inflammation in patients with diverticulitis

FEB 9, 2022
ELIGO v SNIPR: a reflection on IP strategies in a competitive environment
Editor's Choice

ELIGO v SNIPR: a reflection on IP strategies in a competitive environment

FEB 7, 2022
Microbiome of mother’s vagina may affect infant mortality risk and baby’s development
Pharma & Human Health

Microbiome of mother’s vagina may affect infant mortality risk and baby’s development

FEB 4, 2022
Ferring takes pre-emptive action in IP dispute with Finch
Editor's Choice

Ferring takes pre-emptive action in IP dispute with Finch

FEB 2, 2022
Publication of ECOSPOR lll Phase 3 Study Data Evaluating SER-109 in Recurrent C. Difficile Infection
Clinical & Manufacturing

Publication of ECOSPOR lll Phase 3 Study Data Evaluating SER-109 in Recurrent C. Difficile Infection

JAN 24, 2022
Viruses and game theory
Pharma & Human Health

Viruses and game theory

JAN 13, 2022
Researchers discover new hiding place for antibiotic resistance
Infectious Disease & AMR

Researchers discover new hiding place for antibiotic resistance

DEC 20, 2021
SGS Acquisition of Quay Pharma Will Further Strengthen Offering
Finance

SGS Acquisition of Quay Pharma Will Further Strengthen Offering

DEC 16, 2021
Food for Health: A new direction for American Agriculture
Editor's Choice

Food for Health: A new direction for American Agriculture

DEC 14, 2021
EverImmune engages Biose Industrie to manufacture its leading oncology-related Live Biotherapeutic
Finance

EverImmune engages Biose Industrie to manufacture its leading oncology-related Live Biotherapeutic

DEC 13, 2021
CRISPRing the microbiome is just around the corner
Editor's Choice

CRISPRing the microbiome is just around the corner

DEC 10, 2021